Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
Clinical trial NCT04079231 · WITHDRAWN
Trial details
- NCT number
- NCT04079231
- Sponsor
- Novartis Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-01
- Primary completion
- 2023-01-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.